Summary & Overview
CPT 50542: Laparoscopic Renal Mass Ablation (Cryo/RF)
CPT code 50542 covers laparoscopic destruction of renal mass lesions using cryoablation or radiofrequency ablation. This procedure is a minimally invasive surgical option for targeted treatment of renal masses and is relevant nationally for surgical urology, oncology, and outpatient surgical centers. The code captures clinically significant interventions that can affect downstream imaging, follow-up care, and facility billing.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical description of the procedure, the typical sites of service, and the types of situations in which the code is used. The publication also summarizes common billing modifiers and related administrative considerations when available, and provides context for how the procedure fits into surgical oncology and interventional urology service lines.
This report is intended to inform revenue cycle teams, surgical program managers, and policy analysts about the clinical intent and billing context of CPT code 50542, outline what to expect in facility and professional billing workflows, and identify where further data or payer-specific policy reviews are typically required.
Billing Code Overview
CPT code 50542 describes the destruction of renal mass lesion(s) using a laparoscopic approach. The provider may use cryoablation (freezing) or radiofrequency ablation (focused radio waves to burn) to destroy the lesion(s).
-
Service type: Laparoscopic renal mass ablation
-
Typical site of service: Hospital outpatient department or ambulatory surgery center where laparoscopic procedures are performed
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old with an incidentally discovered 2.5–4.0 cm renal cortical mass on abdominal imaging. The patient has preserved renal function but wishes to avoid radical nephrectomy. Preoperative workup includes contrast-enhanced CT or MRI to characterize the lesion, basic labs including renal function and coagulation studies, and anesthetic evaluation for laparoscopic surgery. The urologist schedules a minimally invasive laparoscopic renal mass ablation procedure using either cryoablation or radiofrequency ablation under general anesthesia. Intraoperative workflow: patient positioned in lateral decubitus, laparoscopic ports placed, lesion localized with intraoperative ultrasound or fluoroscopy, and ablation probes placed into the mass. Hemostasis is confirmed, and ports are removed with standard closure. Postoperative care includes monitoring for bleeding, pain control, assessment of urine output and renal function, discharge instructions, and imaging follow-up (typically contrast CT or MRI at 3–6 months) to assess treatment completeness and detect recurrence. Typical sites of service are an ambulatory surgical center or hospital operating room. The service type is a surgical therapeutic, minimally invasive ablative procedure.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing physician reports only the professional component of a separately reportable service (e.g., interpretation of intraoperative imaging if billed separately). |